摘要
目的:探讨腹腔镜辅助食管癌根治术的安全性及可行性。方法:回顾分析159例食管癌患者行腹腔镜辅助食管癌根治术的临床资料。结果:159例手术均获成功,无中转开腹及围手术期死亡病例。手术时间131～420 min,平均(236.67±47.66)min,术后肛门排气时间及住院时间分别为(3.08±1.02)d和(23.49±6.54)d。腔镜淋巴结清扫总数、纵隔及腹腔淋巴结数量平均为(23.49±10.21)枚、(11.34±5.84)枚及(10.63±6.81)枚。23例发生手术相关并发症,均经治疗痊愈。术后近期随访效果良好。结论:腹腔镜辅助胸食管癌根治术(Ivor Lewis)安全、可行,手术安全、微创,值得推广应用。
Objective：To investigate the feasibility and safety of laparoscopic Ivor Lewis esophagectomy for esophageal carcinoma.Methods：There was a retrospective review on the clinical data of 159 patients who were treated by laparoscopic Ivor Lewis esophagectomy.Results：All patients underwent laparoscopic Ivor Lewis esophagectomy and lymphadenectomy successfully without conversion to open surgery and perioperative mortality.The mean operating time,first flatus time and hospital stay of the esophagectomy was（236.67±47.66） min,（3.08±1.02） and（23.49±6.54） d,respectively.The number of harvested lymph nodes of total,the mediastinum and the abdomen was（23.49±10.21）,（11.34±5.84） and（10.63±6.81）,respectively.The short-term result post-operation was well included 23 cases with complication.Conclusions：Laparoscopic Ivor Lewis esophagectomy is a safe,feasible,effective and minimally invasive surgical technique.
出处
《腹腔镜外科杂志》
2011年第12期891-893,共3页
Journal of Laparoscopic Surgery
